Birdwatch Note
2024-03-09 16:01:43 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Ozempic, has not been approved as a "weight loss" drug. Ozempic is meant to be used by type 2 diabetics. https://health.ucdavis.edu/blog/cultivating-health/are-weight-loss-medications-like-wegovy-right-for-you/2023/09#:~:text=Ozempic%20is%20not%20approved%20for,people%20with%20type%202%20diabetes.
Written by 7B393E8E901C57EA3F1C27992EF85F266E2AFB12DEF752EE68C726D65A810EE2
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1765801336451244275
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1766494586342719866
- noteId - 1766494586342719866
- participantId -
- noteAuthorParticipantId - 7B393E8E901C57EA3F1C27992EF85F266E2AFB12DEF752EE68C726D65A810EE2 Participant Details
- createdAtMillis - 1710000103924
- tweetId - 1765801336451244275
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 1
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Ozempic, has not been approved as a "weight loss" drug. Ozempic is meant to be used by type 2 diabetics. https://health.ucdavis.edu/blog/cultivating-health/are-weight-loss-medications-like-wegovy-right-for-you/2023/09#:~:text=Ozempic%20is%20not%20approved%20for,people%20with%20type%202%20diabetes.
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2024-03-09 16:01:43 UTC (1710000103924) |
2024-03-09 22:32:27 UTC (1710023547103) |
CURRENTLY_RATED_HELPFUL | 2024-03-10 02:46:15 UTC (1710038775311) |
CURRENTLY_RATED_HELPFUL | 2024-03-09 22:32:27 UTC (1710023547103) |
CURRENTLY_RATED_HELPFUL |
Note Ratings
| rated at | rated by | |
| 2024-03-09 19:32:00 -0600 | Rating Details | |
| 2024-03-09 16:44:30 -0600 | Rating Details | |
| 2024-03-09 16:34:17 -0600 | Rating Details | |
| 2024-03-09 16:22:59 -0600 | Rating Details | |
| 2024-03-09 16:03:10 -0600 | Rating Details | |
| 2024-03-09 15:15:14 -0600 | Rating Details | |
| 2024-03-09 13:29:22 -0600 | Rating Details | |
| 2024-03-09 11:31:33 -0600 | Rating Details | |
| 2024-03-09 11:17:32 -0600 | Rating Details | |
| 2024-03-09 10:58:07 -0600 | Rating Details | |
| 2024-03-09 10:51:55 -0600 | Rating Details | |
| 2024-03-09 10:50:12 -0600 | Rating Details | |
| 2024-03-09 10:30:21 -0600 | Rating Details | |
| 2024-03-09 10:09:49 -0600 | Rating Details | |
| 2024-03-10 07:38:27 -0500 | Rating Details | |
| 2024-03-10 03:59:15 -0500 | Rating Details | |
| 2024-03-09 23:04:40 -0600 | Rating Details | |
| 2024-03-09 21:11:51 -0600 | Rating Details | |
| 2024-03-09 19:41:58 -0600 | Rating Details | |
| 2024-03-09 19:37:50 -0600 | Rating Details | |
| 2024-03-09 18:42:47 -0600 | Rating Details | |
| 2024-03-09 18:39:03 -0600 | Rating Details | |
| 2024-03-09 17:17:13 -0600 | Rating Details | |
| 2024-03-09 17:04:26 -0600 | Rating Details | |
| 2024-03-09 16:55:54 -0600 | Rating Details | |
| 2024-03-09 14:34:30 -0600 | Rating Details | |
| 2024-03-09 13:44:00 -0600 | Rating Details | |
| 2024-03-09 13:32:31 -0600 | Rating Details | |
| 2024-03-09 13:00:42 -0600 | Rating Details | |
| 2024-03-09 12:56:10 -0600 | Rating Details | |
| 2024-03-09 12:52:26 -0600 | Rating Details | |
| 2024-03-09 12:09:44 -0600 | Rating Details | |
| 2024-03-09 11:44:03 -0600 | Rating Details | |
| 2024-03-09 11:41:24 -0600 | Rating Details | |
| 2024-03-09 11:01:38 -0600 | Rating Details | |
| 2024-03-09 10:57:57 -0600 | Rating Details | |
| 2024-03-10 22:12:06 -0500 | Rating Details | |
| 2024-03-10 08:32:39 -0500 | Rating Details | |
| 2024-03-10 07:45:37 -0500 | Rating Details | |
| 2024-03-09 22:30:25 -0600 | Rating Details | |
| 2024-03-09 19:35:06 -0600 | Rating Details | |
| 2024-03-09 19:25:50 -0600 | Rating Details | |
| 2024-03-09 16:56:02 -0600 | Rating Details | |
| 2024-03-09 16:31:32 -0600 | Rating Details | |
| 2024-03-09 16:22:40 -0600 | Rating Details | |
| 2024-03-09 15:45:14 -0600 | Rating Details | |
| 2024-03-09 14:57:12 -0600 | Rating Details | |
| 2024-03-09 14:48:31 -0600 | Rating Details | |
| 2024-03-09 14:39:07 -0600 | Rating Details | |
| 2024-03-09 13:36:22 -0600 | Rating Details | |
| 2024-03-09 13:08:49 -0600 | Rating Details | |
| 2024-03-09 12:09:31 -0600 | Rating Details | |
| 2024-03-09 11:42:05 -0600 | Rating Details | |
| 2024-03-09 11:29:37 -0600 | Rating Details | |
| 2024-03-09 11:23:02 -0600 | Rating Details | |
| 2024-03-09 11:11:47 -0600 | Rating Details | |
| 2024-03-09 11:09:55 -0600 | Rating Details | |
| 2024-03-09 10:41:56 -0600 | Rating Details | |
| 2024-03-14 06:44:01 -0500 | Rating Details | |
| 2024-03-14 00:48:03 -0500 | Rating Details | |
| 2024-03-14 00:29:29 -0500 | Rating Details | |
| 2024-03-09 18:39:23 -0600 | Rating Details |